NCT05860361 Advanced Proton Therapy Approaches: a Multicenter High-quality Data Registry
| NCT ID | NCT05860361 |
| Status | Recruiting |
| Phase | — |
| Sponsor | European Institute of Oncology |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-04-14 |
| Primary Completion | 2028-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-04-14 with a primary completion date of 2028-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the present registry is to prospectively collect data on patients treated with protontherapy in order to improve knowledge on indication, feasibility, and clinical results of hypofractionated schedules applied in the setting of patients.
Eligibility Criteria
Inclusion criteria: * diagnosis of oncological disease (benign and malignant disease); * candidates to proton therapy; * able to provide informed consent. Exclusion criteria: \- age \< 18 years.
Contact & Investigator
Roberto Orecchia
PRINCIPAL INVESTIGATOR
European Institute of Oncology
Frequently Asked Questions
Who can join the NCT05860361 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05860361 currently recruiting?
Yes, NCT05860361 is actively recruiting participants. Contact the research team at roberto.orecchia@ieo.it for enrollment information.
Where is the NCT05860361 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT05860361 clinical trial?
NCT05860361 is sponsored by European Institute of Oncology. The principal investigator is Roberto Orecchia at European Institute of Oncology. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.